PECAM1

There are 229 papers on PECAM1 in aging research: 8 trials and 64 observational studies in people, 122 in animals, 30 in cells, 4 reviews. The newest story, Nov 9, 2026: “Protein loss weakened barriers in human brain vessel cells”.

Gene

229 papers study it2 findings

HGNCNCBI GeneTaxon

16 new papers in 30 daysSee all 229 papers on PECAM1

At a glance

The findings reach people, from one lab or study. 2 independent labs in 2 countries.

“basal NF-κB phosphorylation inversely correlated with CD31 expression”
Cell generation dynamics underlying naïve T cell homeostasis in adult humansbioRxiv (Cold Spring Harbor Laboratory)2019doi:10.1101/635995

None of its findings points the other way.

Mice and humans: a single group. Cells and worms or flies: nothing yet.
  • 2 independent labs in 2 countries
  • Funders: Cancerfonden and others
  • Human trial8
  • Humans64
  • Animals122
  • Cells30

Interventions

1

miR-200B-3P

upin mice1

1 study
  1. miR-200B-3P increases PECAM1 in mice (diabetic wound healing).

    “CD31 proteins showed a significant increase in the gel+miR-200b-3p group compared with the other three groups.”

    Animalsdiabetic wound healingpoloxamer 407 hydrogelskin14 days

    Topical Application of miR-200b-3p by Poloxamer 407-Based Hydrogel Accelerates Diabetic Wound Healing

    Diabetes, metabolic syndrome and obesity : targets and therapy

More on miR-200B-3P

Associations

1

NF-κB phosphorylation

downin humans1

1 study
  1. PECAM1 is associated with NF-κB phosphorylation in humans.

    “basal NF-κB phosphorylation inversely correlated with CD31 expression”

    HumansCD4+ naïve T cell

    Cell generation dynamics underlying naïve T cell homeostasis in adult humans

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

More on NF-κB phosphorylation

Latest

Dec 2025: 2Jan 2026: 12Feb 2026: 4Mar 2026: 11Apr 2026: 4May 2026: 8Jun 2026: 5Jul 2026: 2Aug 2026: 5Sep 2026: 6Oct 2026: 10Nov 2026: 1180 papers in 12 months
Aging Cell

Protein loss weakened barriers in human brain vessel cells

In lab experiments, reducing alpha-synuclein, a protein, made layers of human brain blood-vessel cells leakier; suppressing an enzyme returned leakage to normal.In lab experiments, reducing alpha-synuclein, a protein, made layers of human brain blood-vessel cells leakier; suppressing an enzyme returned leakage to normal.

Human cell studyMechanisms

See all 229 papers on PECAM1